132 related articles for article (PubMed ID: 35953040)
41. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
[TBL] [Abstract][Full Text] [Related]
42. Understanding the continuum of radionecrosis and vascular disorders in the brain following gamma knife irradiation: An MRI study.
Constanzo J; Masson-Côté L; Tremblay L; Fouquet JP; Sarret P; Geha S; Whittingstall K; Paquette B; Lepage M
Magn Reson Med; 2017 Oct; 78(4):1420-1431. PubMed ID: 27851877
[TBL] [Abstract][Full Text] [Related]
43. Pre-treatment factors associated with detecting additional brain metastases at stereotactic radiosurgery.
Wardak Z; Augustyn A; Zhu H; Mickey BE; Whitworth LA; Madden CJ; Barnett SL; Abdulrahman RE; Nedzi LA; Timmerman RD; Choe KS
J Neurooncol; 2016 Jun; 128(2):251-7. PubMed ID: 26966096
[TBL] [Abstract][Full Text] [Related]
44. A brain MRI dataset and baseline evaluations for tumor recurrence prediction after Gamma Knife radiotherapy.
Wang Y; Duggar WN; Caballero DM; Thomas TV; Adari N; Mundra EK; Wang H
Sci Data; 2023 Nov; 10(1):785. PubMed ID: 37938247
[TBL] [Abstract][Full Text] [Related]
45. Evaluating Critical Brain Radiation Doses in the Treatment of Multiple Brain Lesions with Gamma Knife Radiosurgery.
Hatiboglu MA; Akdur K
Stereotact Funct Neurosurg; 2017; 95(4):268-278. PubMed ID: 28810243
[TBL] [Abstract][Full Text] [Related]
46. Three-dimensional dose verification of the clinical application of gamma knife stereotactic radiosurgery using polymer gel and MRI.
Papagiannis P; Karaiskos P; Kozicki M; Rosiak JM; Sakelliou L; Sandilos P; Seimenis I; Torrens M
Phys Med Biol; 2005 May; 50(9):1979-90. PubMed ID: 15843731
[TBL] [Abstract][Full Text] [Related]
47. Gamma Knife irradiation method based on dosimetric controls to target small areas in rat brains.
Constanzo J; Paquette B; Charest G; Masson-Côté L; Guillot M
Med Phys; 2015 May; 42(5):2311-6. PubMed ID: 25979025
[TBL] [Abstract][Full Text] [Related]
48. A preplanning method for stereotactic radiosurgery to improve treatment workflow.
Ahn KH; Ozturk N; Smith B; Slavin KV; Koshy M; Aydogan B
J Appl Clin Med Phys; 2016 May; 17(3):171-179. PubMed ID: 27167274
[TBL] [Abstract][Full Text] [Related]
49. Dosimetric characterization of hypofractionated Gamma Knife radiosurgery of large or complex brain tumors versus linear accelerator-based treatments.
Dong P; Pérez-Andújar A; Pinnaduwage D; Braunstein S; Theodosopoulos P; McDermott M; Sneed P; Ma L
J Neurosurg; 2016 Dec; 125(Suppl 1):97-103. PubMed ID: 27903198
[TBL] [Abstract][Full Text] [Related]
50. Evaluation of the spatial accuracy of magnetic resonance imaging-based stereotactic target localization for gamma knife radiosurgery of functional disorders.
Bednarz G; Downes MB; Corn BW; Curran WJ; Goldman HW
Neurosurgery; 1999 Nov; 45(5):1156-61; discussion 1161-3. PubMed ID: 10549932
[TBL] [Abstract][Full Text] [Related]
51. Outcomes and prognostic stratification of patients with recurrent glioblastoma treated with salvage stereotactic radiosurgery.
Sharma M; Schroeder JL; Elson P; Meola A; Barnett GH; Vogelbaum MA; Suh JH; Chao ST; Mohammadi AM; Stevens GHJ; Murphy ES; Angelov L
J Neurosurg; 2018 Oct; 131(2):489-499. PubMed ID: 30485180
[TBL] [Abstract][Full Text] [Related]
52. Velocity-based Adaptive Registration and Fusion for Fractionated Stereotactic Radiosurgery Using the Small Animal Radiation Research Platform.
Black PJ; Smith DR; Chaudhary K; Xanthopoulos EP; Chin C; Spina CS; Hwang ME; Mayeda M; Wang YF; Connolly EP; Wang TJC; Wuu CS; Hei TK; Cheng SK; Wu CC
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):841-847. PubMed ID: 29891199
[TBL] [Abstract][Full Text] [Related]
53. Quantitative tumor volumetric responses after Gamma Knife radiosurgery for meningiomas.
Harrison G; Kano H; Lunsford LD; Flickinger JC; Kondziolka D
J Neurosurg; 2016 Jan; 124(1):146-54. PubMed ID: 26162039
[TBL] [Abstract][Full Text] [Related]
54. Tumor habitat analysis by magnetic resonance imaging distinguishes tumor progression from radiation necrosis in brain metastases after stereotactic radiosurgery.
Lee DH; Park JE; Kim N; Park SY; Kim YH; Cho YH; Kim HS
Eur Radiol; 2022 Jan; 32(1):497-507. PubMed ID: 34357451
[TBL] [Abstract][Full Text] [Related]
55. The predictive value of magnetic resonance imaging in evaluating intracranial arteriovenous malformation obliteration after stereotactic radiosurgery.
Lee CC; Reardon MA; Ball BZ; Chen CJ; Yen CP; Xu Z; Wintermark M; Sheehan J
J Neurosurg; 2015 Jul; 123(1):136-44. PubMed ID: 25839923
[TBL] [Abstract][Full Text] [Related]
56. Optimizing intracranial metastasis detection for stereotactic radiosurgery.
Engh JA; Flickinger JC; Niranjan A; Amin DV; Kondziolka DS; Lunsford LD
Stereotact Funct Neurosurg; 2007; 85(4):162-8. PubMed ID: 17259753
[TBL] [Abstract][Full Text] [Related]
57. Integration of the metabolic data of positron emission tomography in the dosimetry planning of radiosurgery with the gamma knife: early experience with brain tumors. Technical note.
Levivier M; Wikier D; Goldman S; David P; Metens T; Massager N; Gerosa M; Devriendt D; Desmedt F; Simon S; Van Houtte P; Brotchi J
J Neurosurg; 2000 Dec; 93 Suppl 3():233-8. PubMed ID: 11143256
[TBL] [Abstract][Full Text] [Related]
58. MRI-based polymer gel dosimetry for validating plans with multiple matrices in Gamma Knife stereotactic radiosurgery.
Gopishankar N; Watanabe Y; Subbiah V
J Appl Clin Med Phys; 2011 Jan; 12(2):3333. PubMed ID: 21587176
[TBL] [Abstract][Full Text] [Related]
59. Clinical outcomes of gamma knife radiosurgery in the salvage treatment of patients with recurrent high-grade glioma.
Elaimy AL; Mackay AR; Lamoreaux WT; Demakas JJ; Fairbanks RK; Cooke BS; Lamm AF; Lee CM
World Neurosurg; 2013 Dec; 80(6):872-8. PubMed ID: 23403349
[TBL] [Abstract][Full Text] [Related]
60. Stereotactic radiosurgery for intracranial metastases: linac-based and gamma-dedicated unit approach.
Alongi F; Fiorentino A; Mancosu P; Navarria P; Giaj Levra N; Mazzola R; Scorsetti M
Expert Rev Anticancer Ther; 2016 Jul; 16(7):731-40. PubMed ID: 27186849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
